Bullseye Trades
Posts
BSEM: From OTC to Nasdaq Contender!

BSEM: From OTC to Nasdaq Contender!

Could Flip the Script in 2026👀

May 13, 2026

*together with BioStem Technologies, Inc.

BSEM Is Heating Up Fast: Seven Straight Profitable Quarters, Fresh Audited Financials, a $40M Expansion Play, and a Nasdaq Uplisting Setup That Could Flip the Script in 2026!

BioStem Technologies Inc. (OTC: BSEM) may be about to level up. While most small-cap MedTech names are still grinding toward profitability, BSEM is already there—seven quarters deep—and now stacking major catalysts on top. The company just dropped audited financials for 2024 and 2025, a key step toward its Nasdaq uplisting ambitions, and paired that with a bold $40 million acquisition that instantly expands its reach into hospitals and surgical centers. With strong revenue, elite margins, and a growing cash position, this isn’t a “maybe someday” story—it’s happening in real time.

What really hits is the combination of execution and upside. BSEM isn’t just growing—it’s scaling into a $300M+ market with clinically validated tech and real adoption across major healthcare channels. Add in a Zacks $25.50 price target and the potential visibility boost from a Nasdaq move, and you’ve got a setup that could shift perception fast.

Tap in and dig deeper to see why BSEM is building serious momentum and positioning itself as one of the most watchable potential breakout plays this year

DISCLAIMER: This publication is owned and operated by Sherwood Ventures LLC (“SV”). Full disclaimer: https://bullseyealerts.com/disclaimer/.

NOT INVESTMENT ADVICE: We are a financial publisher, not a registered investment advisor. Content provided is for informational, educational, and promotional purposes only and should not be considered investment advice or a recommendation to buy or sell any security.

*PAID PROMOTION/COMPENSATION DISCLOSURE: SV has received six thousand dollars cash (via Sideways Frequency) for this one day program on 5/13/26 for marketing efforts to increase public awareness of BioStem Technologies, Inc. (BSEM). SV may have also previously been compensated for similar marketing efforts. As SV has received compensation from these companies, these parties have financial interests in the securities referenced. Further, SV and its affiliates may buy, sell, or hold positions in securities mentioned at any time without notice.

RISK WARNING: Investing involves substantial risk. Securities discussed may be highly speculative and volatile. Past performance is not indicative of future results, and you may lose some or all of your investment. Always consult a licensed financial professional before making investment decisions.